# Camilo Tamayo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/camilo-tamayo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8 |
| Field | Retinal Diseases and Treatments |
| h-index | 2 |
| i10-index | 0 |
| OpenAlex ID | https://openalex.org/A5112132299 |
| Works | 5 |

## Researcher papers

- [Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia](https://scholariq.org/papers/cost-effectiveness-and-budget-impact-analysis-of-the-use-of-faricimab-in-2/)
- [Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia](https://scholariq.org/papers/cost-effectiveness-of-tacrolimus-compared-with-cyclosporine-for/)
- [Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia](https://scholariq.org/papers/cost-effectiveness-and-budget-impact-analysis-of-the-use-of-faricimab-in/)
- [EFFECTIVENESS AND SAFETY OF MACITENTAN IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION](https://scholariq.org/papers/effectiveness-and-safety-of-macitentan-in-the-treatment-of-pulmonary-arterial/)
- [Cost-Effectiveness Analysis of Pharmacological Treatment for Adult Kidney Transplant Recipients in Colombia](https://scholariq.org/papers/cost-effectiveness-analysis-of-pharmacological-treatment-for-adult-kidney/)

## Researcher topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Retinal Imaging and Analysis](https://scholariq.org/topics/retinal-imaging-and-analysis/)
- [Retinal and Optic Conditions](https://scholariq.org/topics/retinal-and-optic-conditions/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.